IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Latest 424B5 SEC Filings
Prospectus [Rule 424(b)(5)]
AVIGEN INC \DE, 424B5, 2000-11-15
AVIGEN INC \DE, 424B5, 2000-11-03
GENOME THERAPEUTICS CORP, 424B5, 2000-07-07
GENOME THERAPEUTICS CORP, 424B5, 2000-07-03
GENOME THERAPEUTICS CORP, 424B5, 2000-06-28
FAQ
|
Privacy
|
Terms Of Service
|
Contact
© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission
